Our Managing Director, Sarah Griffin is  looking forward to participating as an expert panellist for the BiotechTalks on Regulatory and Reimbursement 101: the pathway to commercialisation on Thursday 31 March.

BiotechTalks by AusBiotech is offered by the industry for the industry, and enables the Australian biotechnology industry to stay connected, present ideas, projects and updates, and exchange knowledge.

In this webcast, you will hear from Sarah and other experts about reimbursement for innovative medical technology, which is a significant consideration for any medtech early-stage company or emerging SME. Fuelled by a value-driven healthcare environment, the reimbursement landscape can certainly present a wide spectrum of challenges. Join a panel of experts to learn about the processes that are essential for commercial success in Australia and internationally. The webcast will also explore how to take your idea to a prototype, planning for manufacture, collaborating with “Big Medtech” and taking your product to commercialisation.

To find out more and to register for the webcast, follow the link: BiotechTalks: Regulatory and Reimbursement 101: the pathway to commercialisation – AusBiotech Ltd

If you are not an AusBiotech member, contact Tanya Daw on 0401 408 345 or email membership@ausbiotech.org to find out more about an AusBiotech membership.